Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026)
Bruker (BRKR) posted Total Non-Current Liabilities of $5.5 billion for Q1 2026, up 76.29% on a QoQ basis from $3.1 billion in Q4 2025, and up 4.72% year-over-year from $5.3 billion in Q1 2025.
Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Bruker's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $5.5 billion for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 4.72% year-over-year to $5.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 4.72% YoY) and the FY2025 annual result came in at $3.1 billion, down 14.91% from the prior year.
- Total Non-Current Liabilities was $5.5 billion for Q1 2026 at Bruker, up from $3.1 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.7 billion in Q3 2025 and bottomed at $2.4 billion in Q4 2022.
- A 5-year average of $3.8 billion and a median of $3.4 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 32.36% — and 2025, when it soared 82.5%.
- Bruker's Total Non-Current Liabilities stood at $2.4 billion in 2022, then gained by 17.51% to $2.8 billion in 2023, then soared by 32.76% to $3.7 billion in 2024, then slipped by 14.91% to $3.1 billion in 2025, then soared by 76.29% to $5.5 billion in 2026.
- Business Quant data shows BRKR's Total Non-Current Liabilities at $5.5 billion in Q1 2026, $3.1 billion in Q4 2025, and $5.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 5.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52 Bn |
| Dec 31, 2025 | 3.13 Bn |
| Sep 30, 2025 | 5.74 Bn |
| Jun 30, 2025 | 5.59 Bn |
| Mar 31, 2025 | 5.27 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 4.06 Bn |
| Jun 30, 2024 | 3.90 Bn |
| Mar 31, 2024 | 2.89 Bn |
| Dec 31, 2023 | 2.77 Bn |
| Sep 30, 2023 | 3.42 Bn |
| Jun 30, 2023 | 3.44 Bn |
| Mar 31, 2023 | 3.37 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.96 Bn |
| Jun 30, 2022 | 2.98 Bn |
| Mar 31, 2022 | 3.12 Bn |
| Dec 31, 2021 | 3.49 Bn |
| Sep 30, 2021 | 2.73 Bn |
| Jun 30, 2021 | 2.69 Bn |